BioSpace News Archive

LeafyWell (LeafyWell.com), a subsidiary of NxGen Brands, Inc. (NXGB), today announces uniting with Shari Kaplan Stellino, founder and CEO of Cannectd Biotechnology, (www.Cannectd.com), in offering expert-level input on the creation of new formulations of Cannabidiol (CBD) and especially Cannabigerol (CBG) containing products.

Dreem 2 is a holistic, non-invasive solution, which includes an FDA-registered medical device to help poor sleepers address their problems and improve their sleep.

Joint venture brings together AI technology and living tumor organoids to develop novel personalized therapies for cancer patients

Findings from Pooled Analysis of KEYNOTE-189, KEYNOTE-407 and KEYNOTE-021 (Cohort G) Presented at the IASLC 2019 World Conference on Lung Cancer

The treatment is called GAINSWave®, and is the premium brand of shockwave therapy performed by a highly-trained network of providers across the nation.

Kindred Biosciences, Inc. announced that it has been selected by the National Cancer Institute as one of three contractors in response to the solicitation for the PREVENT Cancer Preclinical Drug Development Program: Current Good Manufacturing Practice Production of Vaccines and Biologicals for Cancer Prevention.

Industry comes together to advance product development and stay ahead of changing regulations

Accuray Incorporated (NASDAQ: ARAY) announced today that the Geisinger Medical Center radiation oncology team is first in Pennsylvania to treat cancer patients with the innovative Radixact® System

Second patent received this month related to sgRNAs for the groundbreaking gene-editing technology

Novigenix SA announced the discovery of a new molecular signature in blood that can be used for early colorectal cancer detection using its new LITOseek™ platform.